Angiotensin type 1 receptor mediates chronic ethanol consumption-induced hypertension and vascular oxidative stress

Vascular Pharmacology

Volumn 74, Issue , 2015, Pages 49-59

  Passaglia, Patrícia ^a   Ceron, Carla S ^a   Mecawi, André S ^a   Antunes Rodrigues, José ^a   Coelho, Eduardo B ^a   Tirapelli, Carlos R ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiotensin II; Ethanol; Hypertension; Oxidative stress; Superoxide anion

Indexed keywords

ALCOHOL; ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN I; ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRATE; NITRITE; POTASSIUM; RENIN; SODIUM; STRESS ACTIVATED PROTEIN KINASE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST;

ALCOHOL CONSUMPTION; ALDOSTERONE BLOOD LEVEL; ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HYPERTENSION; MALE; MESENTERIC ARTERIAL BED; MESENTERIC ARTERY; NONHUMAN; OXIDATIVE STRESS; PLASMA OSMOLALITY; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; VASCULAR OXIDATIVE STRESS; WISTAR RAT; ANIMAL; AORTA; ARTERY; BLOOD PRESSURE; CHEMICALLY INDUCED; DRINKING BEHAVIOR; DRUG EFFECTS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; VASOCONSTRICTION;

ALCOHOL DRINKING; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; AORTA; ARTERIES; BLOOD PRESSURE; ETHANOL; HYPERTENSION; LOSARTAN; MALE; OXIDATIVE STRESS; PHOSPHORYLATION; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RENIN-ANGIOTENSIN SYSTEM; VASOCONSTRICTION;

EID: 84941029641     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2015.04.002     Document Type: Article

References (58)

1. Marchi K.C., Muniz J.J., Tirapelli C.R. Hypertension and chronic ethanol consumption: what do we know after a century of study?. World J Cardiol 2014, 6(5):283-294.
2. O'Keefe J.H., Bhatti S.K., Bajwa A., DiNicolantonio J.J., Lavie C.J. Alcohol and cardiovascular health: the dose makes the poison. . .or the remedy. Mayo Clin Proc 2014, 89(3):382-393.
3. Klatsky A.L., Friedman G.D., Siegelaub A.B., Gérard M.J. Alcohol consumption and blood pressure Kaiser-Permanente Multiphasic Health Examination data. N Engl J Med 1977, 296:1194-1200.
4. Klatsky A.L., Friedman G.D., Armstrong M.A. The relationships between alcoholic beverage use and other traits to blood pressure: a new Kaiser Permanente study. Circulation 1986, 73:628-636.
5. Husain K., Mejia J., Lalla J., Kazim S. Dose response of alcohol-induced changes in BP, nitric oxide and antioxidants in rat plasma. Pharmacol Res 2005, 51(4):337-343.
6. Husain K., Vazquez M., Ansari R.A., Malafa M.P., Lalla J. Chronic alcohol-induced oxidative endothelial injury relates to angiotensin II levels in the rat. Mol Cell Biochem 2008, 307(1-2):51-58.
7. Husain K., Vazquez-Ortiz M., Lalla J. Down regulation of aortic nitric oxide and antioxidant systems in chronic alcohol-induced hypertension in rats. Hum Exp Toxicol 2007, 26:427-434.
8. Tirapelli C.R., Leone A.F., Yogi A., Tostes R.C., Lanchote V.L., Uyemura A.S., Resstel L.B., Corrêa F.M., Padovan C.M., de Oliveira A.M., Coelho E.B. Ethanol consumption increases blood pressure and alters the responsiveness of the mesenteric vasculature in rats. J Pharm Pharmacol 2008, 60(3):331-341.
9. Sönmez M.F., Narin F., Balcioğlu E. Melatonin and vitamin C attenuates alcohol-induced oxidative stress in aorta. Basic Clin Pharmacol Toxicol 2009, 105(6):410-415.
10. Linkola J., Fyhrquist F., Ylikahri R. Renin, aldosterone and cortisol during ethanol intoxication and hangover. Acta Physiol Scand 1979, 106(1):75-82.
11. Wong P.Y., Carroll R.E., Lipinski T.L., Capone R.R. Studies on the renin-angiotensin-aldosterone system in patients with cirrhosis and ascites: effect of saline and albumin infusion. Gastroenterology 1979, 77:1171-1176.
12. Ibsen H., Christensen N.J., Rasmussen S., Hollnagel H., Damkjaer Nielsen M., et al. The influence of chronic high alcohol intake on blood pressure, plasma noradrenaline concentration and plasma renin concentration. Clin Sci (Lond) 1981, 61(Suppl. 7):377s-379s.
13. Wright J.W., Morseth S.L., Abhold R.H., Harding J.W. Elevations in plasma angiotensin II with prolonged ethanol treatment in rats. Pharmacol Biochem Behav 1986, 24:813-818.
14. Touyz R.M., Schiffrin E.L. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 2000, 52(4):639-672.
15. Mehta P.K., Griendling K.K. Angiotensin II cell signalling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007, 292:C82-C97.
16. Danser A.H. Local renin-angiotensin systems: the unanswered questions. Int J Biochem Cell Biol 2003, 35(6):759-768.
17. Okamura T., Miyazaki M., Inagami T., Toda N. Vascular renin-angiotensin system in two-kidney, one clip hypertensive rats. Hypertension 1986, 8:560-565.
18. Touyz R.M. Recent advances in intracellular signalling in hypertension. Curr Opin Nephrol Hypertens 2003, 12:165-174.
19. Montezano A.C., Nguyen Dinh Cat A., Rios F.J., Touyz R.M. Angiotensin II and vascular injury. Curr Hypertens Rep 2014, 16(6):431.
20. Tharaux P.-L., Chatziantoniou C., Fakhouri F., Dussaule J.-C. Angiotensin II activates collagen I through a mechanism involving the MAP/ER kinase pathway. Hypertension 2000, 36:330-336.
21. Touyz R.M. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. Exp Physiol 2005, 90(4):449-455.
22. Shinozaki K., Ayajiki K., Nishio Y., Sugaya T., Kashiwagi A., Okamura T. Evidence for a causal role of the renin-angiotensin system in vascular dysfunction associated with insulin resistance. Hypertension 2004, 43(2):255-262.
23. Nyby M.D., Abedi K., Smutko V., Eslami P., Tuck M.L. Vascular Angiotensin type 1 receptor expression is associated with vascular dysfunction, oxidative stress and inflammation in fructose-fed rats. Hypertens Res 2007, 30(5):451-457.
24. Tirapelli C.R., Leone A.F., Coelho E.B., Resstel L.B., Corrêa F.M., Lanchote V.L., Uyemura S.A., Padovan C.M., de Oliveira A.M. Effect of ethanol consumption on blood pressure and rat mesenteric arterial bed, aorta and carotid responsiveness. J Pharm Pharmacol 2007, 59(7):985-993.
25. Fabiani M.E., Dinh D.T., Nassis L., Casley D.J., Johnston C.I. Comparative in vivo effects of irbesartan and losartan on angiotensin II receptor binding in the rat kidney following oral administration. Clin Sci (Lond) 2000, 99(4):331-341.
26. Yogi A., Callera G.E., Mecawi A.S., Batalhão M.E., Carnio E.C., Antunes-Rodrigues J., Queiroz R.H., Touyz R.M., Tirapelli C.R. Acute ethanol intake induces superoxide anion generation and mitogen-activated protein kinase phosphorylation in rat aorta: a role for angiotensin type 1 receptor. Toxicol Appl Pharmacol 2012, 264(3):470-478.
27. Tirapelli C.R., Casolari D.A., Yogi A., Tostes R.C., Legros E., Lanchote V.L., Uyemura S.A., de Oliveira A.M. Effect of chronic ethanol consumption on endothelin-1 generation and conversion of exogenous big-endothelin-1 by the rat carotid artery. Alcohol 2007, 41(2):77-85.
28. Tirapelli C.R., Legros E., Brochu I., Honoré J.C., Lanchote V.L., Uyemura S.A., de Oliveira A.M., D'Orléans-Juste P. Chronic ethanol intake modulates vascular levels of endothelin-1 receptor and enhances the pressor response to endothelin-1 in anaesthetized rats. Br J Pharmacol 2008, 154(5):971-981.
29. Sentandreu M.A., Toldrá F. A fluorescence-based protocol for quantifying angiotensin-converting enzyme activity. Nat Protoc 2006, 1(5):2423-2427.
30. Gonzaga N.A., Callera G.E., Yogi A., Mecawi A.S., Antunes-Rodrigues J., Queiroz R.H., Touyz R.M., Tirapelli C.R. Acute ethanol intake induces mitogen-activated protein kinase activation, platelet-derived growth factor receptor phosphorylation, and oxidative stress in resistance arteries. J Physiol Biochem 2014, 70(2):509-523.
31. Resstel L.B., Tirapelli C.R., Lanchote V.L., Uyemura S.A., de Oliveira A.M., Corrêa F.M. Chronic ethanol consumption alters cardiovascular functions in conscious rats. Life Sci 2006, 78(19):2179-2187.
32. Urso T., Gavaler J.S., Van Thiel D.H. Blood ethanol levels in sober alcohol users seen in an emergency room. Life Sci 1981, 28:1053-1056.
33. Chan T.C., Wall R.A., Sutter M.C. Chronic ethanol consumption, stress, and hypertension. Hypertension 1985, 7:519-524.
34. Pals D.T., Couch S.J. Renin release induced by losartan (DuP 753), an angiotensin II receptor antagonist. Clin Exp Hypertens 1993, 15(1):1-13.
35. Peters J., Obermüller N., Woyth A., Peters B., Maser-Gluth C., Kränzlin B., Gretz N. Losartan and angiotensin II inhibit aldosterone production in anephric rats via different actions on the intraadrenal renin-angiotensin system. Endocrinology 1999, 140(2):675-682.
36. Antunes-Rodrigues J., De Castro M., Elias L.L., Valença M.M., McCann S.M. Neuroendocrine control of body fluid metabolism. Physiol Rev 2004, 84:169-208.
37. Eisenhofer G., Johnson R.H. Effect of ethanol ingestion on plasma vasopressin and water balance and humans. Am J Physiol 1982, 242:R522-R527.
38. Wang X.M., Lemos J.R., Dayanithi G., Nordmann J.J., Treistman S.N. Ethanol reduces vasopressin release by inhibiting calcium currents in nerve terminals. Brain Res 1991, 551(1-2):338-341.
39. Lohmeier T.E., Cowley A.W., DeClue J.W., Guyton A.C. Failure of chronic aldosterone infusion to increase arterial pressure in dogs with angiotensin-induced hypertension. Circ Res 1978, 43(3):381-390.
40. Isojärvi J.I., Huuskonen U.E., Pakarinen A.J., Vuolteenaho O., Myllylä V.V. The regulation of serum sodium after replacing carbamazepine with oxcarbazepine. Epilepsia 2001, 42(6):741-745.
41. Garwitz E.T., Jones A.W. Aldosterone infusion into the rat and dose-dependent changes in blood pressure and arterial ionic transport. Hypertension 1982, 4(3):374-381.
42. Mujais S.K., Chekal M.A., Jones W.J., Hayslett J.P., Katz A.I. Modulation of renal sodium-potassium-adenosine triphosphatase by aldosterone. Effect of high physiologic levels on enzyme activity in isolated rat and rabbit tubules. J Clin Invest 1985, 76(1):170-176.
43. Rabelink T.J., Koomans H.A., van de Stolpe A., Bijlsma J.A., Dorhout Mees E.J. Effects of atrial natriuretic peptide on distal tubule function in humans. Kidney Int 1990, 37(3):996-1001.
44. Pagano P.J., Ito Y., Tornheim K., Gallop P.M., Tauber A.I., Cohen R.A. An NADPH oxidase superoxide-generating system in the rabbit aorta. Am J Physiol 1995, 268(6 Pt 2):H2274-2280.
45. Ronson R.S., Nakamura M., Vinten-Johansen J. The cardiovascular effects and implications of peroxynitrite. Cardiovasc Res 1999, 44:47-59.
46. Tousoulis D., Simopoulou C., Papageorgiou N., Oikonomou E., Hatzis G., Siasos G., Tsiamis E., Stefanadis C. Endothelial dysfunction in conduit arteries and in microcirculation. Novel therapeutic approaches. Pharmacol Ther 2014, 144(3):253-267.
47. Pearson G., Robinson F., Beers Gibson T., Xu B.-E., Karandikar M., Berman K., Cobb M.H. Mitogen-activated protein kinase pathways: regulation and physiological functions. Endocr Rev 2001, 22:153-183.
48. Zhang X., Wu M., Jiang H., Hao J., Zhang Q., Zhu Q., Saren G., Zhang Y., Meng X., Yue X. Angiotensin II upregulates endothelial lipase expression via the NF-kappa B and MAPK signaling pathways. PLoS One 2014, 9(9). e107634.
49. Viedt C., Soto U., Krieger-Brauer H.I., Fei J., Elsing C., Kübler W., Kreuzer J. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species. Arterioscler Thromb Vasc Biol 2000, 20(4):940-948.
50. Force T., Pombo C.M., Avruch J.A., Bonventre J.V., Kyriakis J.M. Stress-activated protein kinases in cardiovascular disease. Circ Res 1996, 78:947-953.
51. Hiroi Y., Hiroi J., Kudoh S., Yazaki Y., Nagai R., Komuro I. Two distinct mechanisms of angiotensin II-induced negative regulation of the mitogen-activated protein kinases in cultured cardiac myocytes. Hypertens Res 2001, 24(4):385-394.
52. Sun H., Charles C.H., Lau L.F., Tonks N.K. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 1993, 75(3):487-493.
53. Duff J.L., Marrero M.B., Paxton W.G., Charles C.H., Lau L.F., Bernstein K.E., Berk B.C. Angiotensin II induces 3CH134, a protein-tyrosine phosphatase, in vascular smooth muscle cells. J Biol Chem 1993, 268(35):26037-26040.
54. Racz B., Hanto K., Tapodi A., Solti I., Kalman N., Jakus P., Kovacs K., Debreceni B., Gallyas F., Sumegi B. Regulation of MKP-1 expression and MAPK activation by PARP-1 in oxidative stress: a new mechanism for the cytoplasmic effect of PARP-1 activation. Free Radic Biol Med 2010, 49(12):1978-1988.
55. Kim B., Kim J., Bae Y.M., Cho S.I., Kwon S.C., Jung J.Y., Park J.C., Ahn H.Y. p38 mitogen-activated protein kinase contributes to the diminished aortic contraction by endothelin-1 in DOCA-salt hypertensive rats. Hypertension 2004, 43(5):1086-1091.
56. Kiemer A.K., Weber N.C., Fürst R., Bildner N., Kulhanek-Heinze S., Vollmar A.M. Inhibition of p38 MAPK activation via induction of MKP-1: atrial natriuretic peptide reduces TNF-alpha-induced actin polymerization and endothelial permeability. Circ Res 2002, 90(8):874-881.
57. Xing J., Birukova A.A. ANP attenuates inflammatory signaling and Rho pathway of lung endothelial permeability induced by LPS and TNFalpha. Microvasc Res 2010, 79(1):56-62.
58. Nemenoff R.A. Vasopressin signaling pathways in vascular smooth muscle. Front Biosci 1998, 3:d194-207.